Posts

Showing posts from August, 2022

Wound Debridement Market Players: Acelity L.P. Inc., Smith & Nephew, B. Braun Melsungen AG, And Coloplast A/S

  Wound Debridement Industry Overview The global wound debridement market size was valued at USD 3.97 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028. The high incidence of chronic conditions, such as pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed economies, and changing lifestyles are anticipated to drive the market. Furthermore, increasing incidence of accidents such as road accidents, burns, and trauma events across the globe is anticipated to drive the market. Additionally, the widening base of the geriatric population and increasing initiatives by the governments and private organizations to raise awareness regarding wound care treatment are projected to work in favor of the market. Gather more insights about the market drivers, restrains and growth of the Global Wound Debridement market The COVID-19 outbreak has created large-scale opportunities for ...

Drug Of Abuse Testing Services Market: Opioids Drug Type Segment Held A Significant Revenue Share

  Drug Of Abuse Testing Services Industry Overview The global drug of abuse testing services market size was valued at USD 2.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2028. An increase in the consumption of alcohol and illicit drugs has led to the high growth of the market. The rise in government initiatives to monitor and combat substance abuse is also significantly driving the market. According to the United Nations Office on Drugs and Crime (UNODC) 2019 data, around 35 million people with substance use disorders were in need of treatment globally. Around 55% of the substance use disorders are associated with opioids and 25% with marijuana. In 2017, 188 million past-year cannabis users were estimated across the world, as per the UNODC data. On the basis of the National Center for Drug Abuse Statistics (NCDAS), around 1.5% to 5% of diseases are direct consequences of using illegal drugs or alcohol addiction. Access a...

Genome Editing Market Players: Cellectis S.A., Astrazeneca, Takara Bio USA, And Egenesis Inc.

  Genome Editing Industry Overview The global genome editing market size was valued at USD 3.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 22.9% from 2021 to 2028. Increasing implementation of CRISPR genome editing technology coupled with rising synthetic gene demand in diverse biotechnology domains has primarily driven the market growth over the past few years. Furthermore, the development of CRISPR -based novel diagnostic tools to mitigate the adverse impact of the COVID-19 pandemic is driving the market. For instance, in March 2021, a team of researchers from the Nanyang Technological University developed a diagnostic test - VaNGuard (Variant Nucleotide Guard) based on CRISPR technology. This test can detect mutated SARS-CoV-2 strains, thereby increasing the adoption of CRISPR genome editing technology in the diagnostics arena. Gather more insights about the market drivers, restrains and growth of the Global Genome Editing market Apa...

CRISPR And Cas Genes Market Players: Lonza, Merck Kgaa, Takara Bio Inc., And Synthego

  CRISPR And Cas Genes Industry Overview The global CRISPR and cas genes market size was valued at USD 1.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.7% from 2021 to 2028. 2020 was a remarkable year for the market as the Nobel Prize in Chemistry was received by Emmanuelle Charpentier and Jennifer A. Doudna for the breakthrough research in CRISPR/Cas9 genetic scissors for genome editing, thereby positively impacting the market. Furthermore, the development of CRISPR-based diagnostic tests to address the timeline and sample collection challenges for COVID-19 screening is driving the market. The tests are designed to offer advantages such as high precision and sensitivity, rapid detection, no requirement of special laboratory equipment, and portability. For instance, in December 2020, researchers from Gladstone Institutes developed a CRISPR-based test that uses smartphones to deliver results. Gather more insights about the market drivers...